Birgit Meyer‐Puttlitz
Sanofi (Germany)(DE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Glycosylation and Glycoproteins Research, Proteoglycans and glycosaminoglycans research, Neurofibromatosis and Schwannoma Cases, Hedgehog Signaling Pathway Studies
Most-Cited Works
- → PTEN mutations in gliomas and glioneuronal tumors(1998)339 cited
- → Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic Meningiomas(2001)272 cited
- → Molecular Genetic Analysis of Ependymal Tumors(1999)252 cited
- → Impact of Genotype and Morphology on the Prognosis of Glioblastoma(2002)212 cited
- → Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes(2017)178 cited
- → Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors(2000)152 cited
- → Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan(1996)148 cited
- → High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples(2001)137 cited
- → Chondroitin Sulfate and Chondroitin/Keratan Sulfate Proteoglycans of Nervous Tissue: Developmental Changes of Neurocan and Phosphacan(1995)124 cited
- Molecular genetic analysis of giant cell glioblastomas.(1997)